ABSTRACT The metabolic fate of homologous high density lipoprotein (HDL) was studied in the rat, tracing the apoprotein A-I (apo A-I) and cholesterol ester moieties simultaneously. The apo A-I was labeled with covalently linked "MI-labeled tyramine cellobiose, which accumulates in the cells degradingthe apoprotein; [3H]cholesterol ethers, which cannot be hydrolyzed or mobilized after uptake, were incorporated into the lipid core of reconstituted HDL to reflect the fate of the cholesterol esters. Several lines of evidence, including direct comparison with biologically labeled HDL, are presented to support the validity of this approach. The liver was the major organ of cholesterol ether uptake, accounting for 65% of the total; the adrenal gland and ovary were the most active organs per gram (wet) of weight. Uptake of cholesterol ether was 7-fold-greater than that-of apo A-I in adrenal, 4-fold greater in the ovary, and >2-fold greater in the liver. The remaining tissues took up apo A-I and cholesterol ethers at more nearly equal rates. Transfer of HDL-associated cholesterol ethers and 'RI-labeled apo A-I to other lipoprotein fractions was not observed; thus, the results reflect direct uptake from HDL itself. Whereas uptake of low density lipoprotein appears to involve endocytosis of intact particles, uptake of HDL in at least some rat tissues involves additional, more complex, transfer mechanisms.
The increasingly impressive evidence that risk of coronary heart disease correlates inversely with plasma high density lipoprotein (HDL) levels (1) has stimulated a great deal of research on HDL metabolism. This protective effect may be related to HDLmediated transport of cholesterol from extrahepatic tissues to the liver, as postulated by Glomset (2) , but evidence for such "reverse cholesterol transport" in vivo is largely indirect and almost no quantitative data are available. HDL can also, at least in the rat, deliver cholesterol to steroidogenic tissues (3, 4) . This delivery may be receptor mediated although the targeting.of HDL for such uptake is poorly understood.
We have used nondegradable markers to determine simultaneously the uptake of HDL-associated apoprotein A-I (apo A-I) and cholesterol esters by various tissues in vivo. Apo A-I was traced by covalently attaching to it "2I-labeled tyramine-cellobiose (lasI-TC). The TC moiety, which can be radioiodinated to high specific activity, remains trapped in tissues after uptake and degradation of the labeled protein because it cannot be degraded by mammalian cells and does not readily cross cell membranes (5) . The fate of cholesterol esters was determined by using [3H] cholesteryl linoleyl ether as a marker, as described (6) . Since cholesterol ethers cannot be hydrolyzed by mammalian cells, they remain trapped in tissues after uptake in the same manner as the nondegradable-protein marker. Cholesterol ethers were introduced' into HDL by a modification of the procedure for reconstituting low density lipoprotein (LDL) (7) .
The rat was chosen for these studies in part to evaluate further the special role of HDL in this animal for delivering cholesterol to the adrenal gland and gonads and in part because the rat has little or no cholesterol ester exchange protein in its plasma (8) . In the rabbit-and probably in other species with plasma cholesterol ester-exchange protein-cholesterol ethers, like cholesterol esters, exchange rapidly among lipoprotein fractions (9) . This makes it very difficult to be certain which lipoprotein fraction is responsible for observed tissue uptake. In the present studies in the rat, HDL-associated cholesterol ethers did not redistribute to other lipoproteins after injection. Thus, accumulation of cholesterol ethers by tissues resulted from delivery by HDL itself.
MATERIALS AND METHODS
Lipoproteins. HDL was isolated in the density interval 1.09-1.21 g/ml from serum of large female Sprague-Dawley rats (retired breeders) by using sequential ultracentrifugation according to standard techniques (10) . Apo A-I was purified and labeled with '"I-TC as described (11) . '"I-TC-labeled apo A-I (125I-TC-apo A-I) was reassociated with HDL by incubation for 1 hr at 370C in phosphate-buffered saline (pH 7.4) (Pi/NaCl) at a ratio of 1 mol of '"I-TC-apo A-I per 20 mol of HDL. Unbound apo A-I was removed by flotation of the HDL at a salt density of 1.21 g/ml.
To biologically label rat HDL in the cholesterol ester moiety, rats were fasted overnight and then fed [la,2a-3H]cholesterol (Amersham) in 0.5 ml of corn oil delivered through a gastric tube. Serum was recovered 22 (14) . Tissues were collected 24 hr after injection and homogenized as described (11) . In some experiments, hepatocytes and nonparenchymal cells were isolated after collagenase perfusion of the liver (15) .
Radioassay Procedures. Samples containing 1251 or 3H were radioassayed using standard techniques. To assay 3H in tissue homogenates containing both "2I and 3H, samples were brought to a volume of 1 ml with waters and extracted using the method of Dole (16) . This resulted in nearly quantitative recovery of cholesterol ethers in the nonpolar phase (93.5 2.7%) with virtually no contamination by 125I-TC-labeled protein or its degradation products (<0.5% of -total 125I).
RESULTS
Characterization of doubly labeled reconstituted HDL reisolated in the density interval 1.07-1.21 g/ml is shown in Fig. 1. 125I-TC-apo A-I and 3H-labeledcholesteryl linoleyl ether migrated together with a mobility on agarose gel electrophoresis (Fig. 1A ). There was no evidence for a class of particles containing.cholesterol ethers but no apo A-I. As shown in Fig. 1B In studies to be reported elsewhere, the effect of reconstitution on HDL-cell interaction was tested in cultured rat hepatocytes. Uptake of TC-labeled native HDL was identical to that of TC-labeled reconstituted HDL. Unlabeled native HDL competed equally for uptake of both labeled preparations.
The plasma decay kinetics of reconstituted HDL were compared with those of cholesterol esters in a native particle. Re (Table 3) . Calculated this way, the adrenal glands and ovaries were the most active organs in uptake of [3H]cholesteryl linoleyl ether per gram of tissue. The liver exhibited the next highest rate of uptake. The kidney was the most active organ in uptake of 1"I-TC-apo A-I, followed by adrenal, ovary, and liver. These tissues were substantially more active in uptake of '"I-TC-apo A-I and [3H]cholesterol ethers than any of the remaining tissues.
A particularly striking finding was the differential rate of uptake of apo A-I and cholesterol ethers in adrenal, ovary, and liver. Cholesterol ether/apo A-I uptake ratios for these and several other tissues are also shown in Table 3 . The ratio was highest in adrenal (7.0) and definitely >1 in ovary (4.6) and liver (2.2). The kidney also exhibited a striking degree of dissociation but in the opposite direction. Apo A-I uptake in kidney occurred some 30 times faster than that of the ether. Most of the remaining tissues exhibited ether/apo A-I uptake ratios that were not significantly different from 1.
Several possibilities were considered that might account for the differential rates of uptake observed in liver, adrenal, and ovary. One possible explanation is selective uptake of an etherrich particle. However, a minor contaminant of ether-rich particles in the injected preparation could not account for the findings in liver. Tissue content of radioactivity was measured after >90% of the two labels had decayed from the plasma and the liver had taken up more than half of the injected dose. The large fraction of ether-rich particles needed to explain these findings could not have been overlooked. Nevertheless, to directly assess this possibility, doubly labeled reconstituted HDL was separated into heavy and light density subfractions by preparative equilibrium density gradient ultracentrifugation and the tissue uptake of the two fractions was compared. The heavy HDL fraction (1.10-1.21 g/ml) was relatively rich in 12'I-TCapo A-I while the light fraction (1. 065-1. 10 g/ml) was relatively Table 4 , uptake of ether label was at least 2-fold greater than apo A-I uptake in liver, adrenal, and ovary; there were no apparent differences between dense and light HDL subfractions.
To address the possibility that these differential rates of uptake were the consequence of an artifact of reconstitution, HDL that had been biologically labeled in the cholesterol ester moiety was reassociated with 125I-TC-apo A-I and injected into experimental animals. One hour after injection, hepatocytes and adrenal cells were isolated as described (15, 18) and their contents of 3H and 1"I were determined. The 1-hr time period was chosen to minimize hydrolysis of cholesterol esters and loss of radiolabeled cholesterol from tissues. Radioactivity was determined in isolated cells to avoid contamination by the large fraction of the injected dose still in the plasma compartment or extravascular space 1 hr after injection. Results of these experiments are shown in Table 4 . The ratio of the uptake of cholesterol esters and apo A-I by hepatocytes was in good agreement with those obtained using reconstituted HDL. The ratio in adrenal, however, was significantly less than that observed using reconstituted HDL. Since the adrenal uses lipoprotein cholesterol for steroid hormone production (19) , it was possible that radiolabeled cholesterol esters might have been lost at a significant rate due to conversion to steroids and secretion during the course of the experiment. This possibility was examined by administration of 25 mg of aminoglutethamide to each of two rats 1 hr before injection of the labeled HDL. Aminoglutethamide is known to block side-chain cleavage of cholesterol, a step required in the production of corticosteroids (20) . Prior treatment with this agent doubled the cholesterol ester/apo A-I ratio subsequently found in adrenal cells after injection of the doubly labeled HDL. Thus, even though blockade of cholesterol label leakage was probably incomplete, these experiments show the preferential uptake of esters compared with apo A-I from "native" HDL (i.e., HDL not subjected to the reconstitution procedure).
Another possible explanation for the disproportionately greater uptake of cholesterol ether and esters is their transfer to lower density lipoprotein fractions without parallel transfer of apo A-I followed by more rapid tissue uptake of these lighter lipoproteins. Since rat plasma contains little or no cholesterol ester exchange activity, this possibility seemed unlikely but it was checked. A rat was injected with doubly labeled reconstituted HDL. Serum was obtained 1 hr later and chromatographed on 6% agarose. As shown in Fig. 3 , both the apo A-I and cholesterol ether labels eluted exclusively in the HDL range; there was no evidence of transfer of cholesterol ethers to lighter lipoproteins.
DISCUSSION
Several lines of evidence support the conclusion that the metabolism of the nondegradable markers on reconstituted HDL reflects the metabolism of apo A-I and cholesterol esters of native HDL. (i) The physical properties (electrophoretic mobility and hydrated density), apoprotein composition, and lipid composition of the reconstituted HDL closely resemble those of native HDL except for a somewhat lower cholesterol ester/protein ratio. (ii) Unlabeled native HDL competed equally with reconstituted 125I-TC-labeled HDL and with HDL directly conjugated with 15I-TC for uptake and degradation in a cultured rat hepatocyte system. (iii) The in vivo plasma decay rate for cholesterol esters in biosynthetically labeled HDL was identical to that of cholesterol ethers in HDL reconstituted in vitro (and previously biologically screened in a donor animal). We have shown previously that the in vivo plasma decay rate for TC-labeled apo A-I is not different from that of conventionally iodinated apo A-I (11) .
The present results are in good agreement with those previously reported for the sites of degradation of apo A-I on HDL that had not been reconstituted (11) . In those studies, the overall fraction of apo A-I degraded by kidney (37%) was significantly greater than that observed in the present studies. This difference is likely to be due to the combination of ultracentrifugal flotation and biological screening carried out on reconstituted HDL in the present studies. Although the kidneys accounted for 18% of total apo A-I uptake, they took up almost no cholesterol ether (<1%). This supports our previous proposal that the renal degradation represents primarily tubular degradation of filtered free apo A-I in equilibrium with apo A-I on HDL (11) . Estimating the filtration fraction for apo A-I from published data for other macromolecules (21), we calculate that as little as 1-2% unassociated apo A-I could account for the observed results. This selective renal degradation of a significant fraction of plasma apo A-I without concomitant uptake of the cholesterol ether would tend to make the FCR of apo A-I greater than that of cholesterol ether. However, the dispro-portionate uptake of cholesterol ether in liver, adrenal, and ovary overrides this, so that the observed FCR for the ether (0.14 hr-1) is greater than that for A-I (0.11 hr-'). categories of mechanism may be considered. In the first case, uptake of cholesterol esters could occur without uptake of the remainder of the HDL particle-e.g., through binding of HDL to the cell surface with consequent selective transfer of cholesterol esters into the cell. In the second case, uptake of the HDL particle could occur without parallel degradation of apo A-I, either through loss of apo A-I before or during binding of HDL to the cell surface or by uptake of the entire HDL particle with subsequent release of apo A-I from the cell. Differential rates of uptake of the apoprotein and cholesterol ester moieties of chylomicrons have been observed in the perfused rat heart (23) and in rat heart mesenchymal cells in culture (24, 25) . The selective uptake of cholesterol esters from chylomicrons appears to be facilitated by lipoprotein lipase (25) , but the mechanisms responsible are not known. In the present studies, substantial dissociation in the rates of uptake of HDL-associated cholesterol esters and apo A-I occurred only in three tissues, each of them highly active in uptake of apo A-I, and each of them having a specialized role in cholesterol metabolism.
